SCHEMBL29566813

SCHEMBL29566813

CNC(=O)c1ccc(Oc2cc(C3CCOC(C)(C)C3)nc(NS(=O)(=O)c3cnn(C)c3)n2)cn1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HRH3 Q9Y5N1 4/20 0.37
▸ HRH1 P35367 1/20 0.34
▸ GRM4 Q14833 3/20 0.34
▸ TTK P33981 1/20 0.33
▸ JAK1 P23458 1/20 0.32
▸ PARP1 P09874 1/20 0.32
▸ SCN9A Q15858 2/20 0.32
▸ POLB P06746 1/20 0.31
▸ SLC8A1 P32418 1/20 0.31
▸ TP53 P04637 1/20 0.31
▸ PKM P14618 1/20 0.31
▸ WNT1 P04628 1/20 0.31
▸ CLK2 P49760 1/20 0.31
▸ CLK3 P49761 1/20 0.31
▸ GSK3B P49841 1/20 0.31
▸ DYRK1A Q13627 1/20 0.31
▸ KAT6A Q92794 1/20 0.31
▸ KAT5 Q92993 1/20 0.31
▸ SLC6A9 P48067 1/20 0.31
▸ PDE10A Q9Y233 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26807654 1.00 HRH3 (0.37) HRH3HRH1GRM4TTKJAK1
SCHEMBL26807622 0.87 HRH3 (0.43) HRH3HRH1TTKJAK1PARP1
SCHEMBL26807733 0.86 HRH3 (0.42) HRH3HRH1TTKJAK1PARP1
SCHEMBL26810541 0.86 HRH3 (0.39) HRH3HRH1TTKJAK1PARP1
SCHEMBL24310300 0.86 HRH3 (0.35) HRH3HRH1GRM4TTKWNT1
SCHEMBL26807731 0.85 HRH3 (0.39) HRH3HRH1TTKJAK1PARP1
SCHEMBL29567582 0.85 HTR1A (0.38) JAK1SCN9ASLC8A1
SCHEMBL24309633 0.85 HTR1A (0.38) JAK1SCN9ASLC8A1
SCHEMBL26807618 0.83 HRH3 (0.39) HRH3HRH1TTKJAK1PARP1
SCHEMBL24309812 0.82 HRH3 (0.41) HRH3HRH1TTKJAK1PARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225748-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-08-16 — — EP disclosed
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback